Economic burden of hepatitis C in Canada and the potential impact of prevention
Author
Abstract
Suggested Citation
DOI: 10.1007/s10198-004-0273-y
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Shiell, Alan & Law, Matthew G, 2001. "The cost of hepatitis C and the cost-effectiveness of its prevention," Health Policy, Elsevier, vol. 58(2), pages 121-131, November.
- Wong, J.B. & McQuillan, G.M. & McHutchison, J.G. & Poynard, T., 2000. "Estimating future hepatitis C morbidity, mortality, and costs in the United States," American Journal of Public Health, American Public Health Association, vol. 90(10), pages 1562-1569.
- Henke, Klaus-Dirk & Behrens, Cornelia S., 1986. "The economic cost of illness in the Federal Republic of Germany in the year 1980," Health Policy, Elsevier, vol. 6(2), pages 119-143.
- Shiell, Alan & Gerard, Karen & Donaldson, Cam, 1987. "Cost of illness studies: An aid to decision-making?," Health Policy, Elsevier, vol. 8(3), pages 317-323, December.
- Hartunian, N.S. & Smart, C.N. & Thompson, M.S., 1980. "The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: A comparative analysis," American Journal of Public Health, American Public Health Association, vol. 70(12), pages 1249-1260.
- Van Doorslaer, Eddy & Bouter, Lex, 1990. "Assessing the economic burden of injuries due to accidents: methodological problems illustrated with some examples from the literature," Health Policy, Elsevier, vol. 14(3), pages 253-265, May.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Tarricone, Rosanna, 2006. "Cost-of-illness analysis: What room in health economics?," Health Policy, Elsevier, vol. 77(1), pages 51-63, June.
- Shiell, Alan & Law, Matthew G, 2001. "The cost of hepatitis C and the cost-effectiveness of its prevention," Health Policy, Elsevier, vol. 58(2), pages 121-131, November.
- Keith Tolley;Gareth Morgan;Ray Cartwright;Rhys Williams, 1998. "Economic Aspects of Non-Hodgkin's Lymphoma," Series on Health 000436, Office of Health Economics.
- Ebere Akobundu & Jing Ju & Lisa Blatt & C. Mullins, 2006. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 24(9), pages 869-890, September.
- Belaya, V. & Hansen, H. & Pinoir, B., 2013. "Measuring the Costs of Foodborne Diseases: A Review and Classification of the Literature," Proceedings “Schriften der Gesellschaft für Wirtschafts- und Sozialwissenschaften des Landbaues e.V.”, German Association of Agricultural Economists (GEWISOLA), vol. 48, March.
- Smith, Kirsteen & Wright, Ken, 1996. "Costs of mental illness in Britain," Health Policy, Elsevier, vol. 35(1), pages 61-73, January.
- Mark S. Thompson, 1983. "Health Versus Money," Medical Decision Making, , vol. 3(3), pages 285-297, August.
- Furmanov, Kirill & Chernysheva, Irina, 2012. "Health and job search in Russia," Applied Econometrics, Russian Presidential Academy of National Economy and Public Administration (RANEPA), vol. 26(2), pages 62-91.
- Olena Hankivsk & Jane Friesen & Colleen Varcoe & Fiona MacPhail & Lorraine Greaves & Charmaine Spencer, 2004. "Expanding Economic Costing in Health Care: Values, Gender and Diversity," Canadian Public Policy, University of Toronto Press, vol. 30(3), pages 257-282, September.
- Allison Larg & John Moss, 2011. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 29(8), pages 653-671, August.
- Cawley, John & Meyerhoefer, Chad, 2012.
"The medical care costs of obesity: An instrumental variables approach,"
Journal of Health Economics, Elsevier, vol. 31(1), pages 219-230.
- John Cawley & Chad Meyerhoefer, 2010. "The Medical Care Costs of Obesity: An Instrumental Variables Approach," NBER Working Papers 16467, National Bureau of Economic Research, Inc.
- Martin Zalesak & Kevin Francis & Alex Gedeon & John Gillis & Kyle Hvidsten & Phyllis Kidder & Hong Li & Derek Martyn & Leslie Orne & Amanda Smith & Ann Kwong, 2013. "Current and Future Disease Progression of the Chronic HCV Population in the United States," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-10, May.
- Douglas Coyle, 1993. "Increasing the impact of economic evaluations on health care decision-making," Working Papers 108chedp, Centre for Health Economics, University of York.
- Sowmya Dhanaraj, 2014.
"Health Shocks and Coping Strategies: State Health Insurance Scheme of Andhra Pradesh, India,"
WIDER Working Paper Series
wp-2014-003, World Institute for Development Economic Research (UNU-WIDER).
- Sowmya Dhanaraj, 2015. "Health Shocks and Coping Strategies: State Health Insurance Scheme of Andhra Pradesh, India," Working Papers 2015-120, Madras School of Economics,Chennai,India.
- Randall M. Packard, 2009. "“Roll Back Malaria, Roll in Development”? Reassessing the Economic Burden of Malaria," Population and Development Review, The Population Council, Inc., vol. 35(1), pages 53-87, March.
- Teresa Kauf & Ateesha Mohamed & A. Hauber & Derek Fetzer & Atiya Ahmad, 2012. "Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 5(4), pages 265-278, December.
- Sebastian Gurtner, 2013. "An analysis of the influence of framework aspects on the study design of health economic modeling evaluations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(2), pages 221-230, April.
- Marcello Basili & Filippo Belloc, 2012. "How to Measure the Economic Impact of Vector-Borne Diseases at a Country Level: An Assessment," Department of Economics University of Siena 648, Department of Economics, University of Siena.
- Dixon, Padraig & Harrison, Sean & Hollingworth, William & Davies, Neil M. & Davey Smith, George, 2022. "Estimating the causal effect of liability to disease on healthcare costs using Mendelian Randomization," Economics & Human Biology, Elsevier, vol. 46(C).
- Amy O’Sullivan & Jaime Rubin & Joshua Nyambose & Andreas Kuznik & David Cohen & David Thompson, 2011. "Cost Estimation of Cardiovascular Disease Events in the US," PharmacoEconomics, Springer, vol. 29(8), pages 693-704, August.
More about this item
Keywords
Economic burden; Hepatitis C; Markov model; Incidence; Prevention;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:6:y:2005:i:2:p:159-165. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.